Rigel Pharmaceuticals
RIGL
#7173
Rank
S$0.60 B
Marketcap
S$32.61
Share price
-3.56%
Change (1 day)
20.51%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): S$0.15 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are S$0.28 Billion. In 2024 the company made an earning of S$33.68 Million, an increase over its 2023 earnings that were of -S$23.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.15 B368.95%
2024 S$33.68 M-244.27%
2023 -S$23.36 Million-66.79%
2022 -S$70.33 Million340.73%
2021 -S$15.96 Million-56.15%
2020 -S$36.39 Million-57.34%
2019 -S$85.31 Million-7.66%
2018 -S$92.39 Million-9.47%
2017 -S$0.11 Billion24.46%
2016 -S$82 Million23.63%
2015 -S$66.32 Million-43.29%
2014 -S$0.12 Billion2.5%
2013 -S$0.12 Billion
2010 S$48.52 M-133.97%
2009 -S$0.15 Billion-18.49%
2008 -S$0.18 Billion71.91%
2007 -S$0.11 Billion84.74%
2006 -S$55.18 Million-10.17%
2005 -S$61.43 Million-15.73%
2004 -S$72.89 Million39.29%
2003 -S$52.33 Million10.3%
2002 -S$47.45 Million48.3%
2001 -S$32 Million-2.13%
2000 -S$32.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$10.56 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.77 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-S$0.14 Billion-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
-S$0.17 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA